Navigation Links
New, Fast Forensic Technology Wins R&D 100 Award
Date:9/25/2008

ALPHARETTA, Ga., Sept. 25 /PRNewswire/ -- Identity Sciences, LLC (IDS), with its strategic science partner the Idaho National Laboratory (INL), has been awarded a 2008 R&D 100 Award for AbP ID(TM), a new groundbreaking forensic human identification test. The new product, scheduled to be available to forensic labs in late 2009 or early 2010, will be used as a screening tool for DNA and can deliver accurate, reliable results in as little as two hours.

The R&D 100 Awards are considered to be the most prestigious honor in Applied Research. Each year the Award recognizes the 100 most technologically significant new products, processes, materials and software developed throughout the world. It is the only industry-wide competition rewarding the practical applications of science.

Awards are based on each achievement's technical significance, uniqueness and usefulness compared to competing projects and technologies. The Chicago Tribune calls the award "The Oscars of Invention." Previous winners include the fax machine, the Automated Teller Machine (ATM), the cancer drug Taxol, the Nicoderm anti-smoking patch and HDTV.

"Identity Sciences is honored to have AbP ID judged to be one of the top 100 scientific achievements of 2008," says Gene Venesky, CEO of Identity Sciences. "We believe AbP ID will make significant contributions and advancements, not only in the field of forensics, but in homeland security, personnel recovery and healthcare, both nationally and internationally," he adds.

The AbP ID test analyzes Individual Specific Auto-antibodies (ISAs), found in all human body tissues and fluids. It is unlike the current standard forensic testing method which reads DNA in human cells. The AbP ID test can determine whether the antibody profile of the evidence found at a crime scene matches the profile of a suspect. The initial product release will use blood serum and dried blood, and will provide results in just two hours. Other AbP ID tests which are now in development will use semen, saliva and perspiration, delivering results in less than five hours.

AbP ID is considered a breakthrough technology because it can provide test results quickly, without the use of expensive equipment or highly skilled lab technicians. The tests can be conducted in law enforcement crime labs, avoiding lengthy backlogs in specialized labs. AbP ID tests will initially be most effective as a fast, cost-effective screening tool to determine which suspects and evidence should undergo DNA testing.

Image ID(TM), a proprietary software program and 2003 R&D 100 Award recipient, works hand-in-hand to read the AbP ID test results and determine whether there is a match or no match between the evidence and a suspect. The Image ID software package also accumulates crime lab test results for future use. These results can then be transferred to domestic and international databases for expanded test comparisons.

For more information, please contact Carol Haas at (561) 241-6988 or chaas@identitysciences.com and visit our website at http://www.identitysciences.com.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Identity Sciences, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Identity Sciences Introduces a New, Fast Forensic Human I.D. Test
2. Orchid Cellmark Applauds Expansion of Federal Forensic DNA Identity Testing to Include All Arrestees
3. GenVault and the National Center for Forensic Science to Present Novel Technology for Room Temperature Storage of RNA
4. Nuvelo and ARCA biopharma Announce Merger Agreement Creating Late-Stage Cardiovascular Biotechnology Company
5. New Report on 633 Biotechnology Medicines Under Development Released in Michigan
6. Pressure Cycling Technology (PCT) Highlighted in Five Podium Presentations at the Fifth International Conference on High Pressure; PBI Introduces the Patent-pending PCT Shredder at the Meeting
7. Investment and Growth in US Medical Technology Industry Continues Despite Challenging Public Markets
8. Chief Technology Officer Joins ACAMP
9. Varian Medical Systems Exhibits a New Version of RapidArc(TM) Radiotherapy Technology and Other Products for Fast, Precise Cancer Treatment
10. Varian to Showcase RapidArc(TM) Radiotherapy Technology Enhancements at ASTRO 2008
11. Oklahoma CyberKnife Center Cuts Treatment Time in Half With Next Generation CyberKnife Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 01, 2016 , ... ... value of DNA microarray comparative genomic hybridization (array CGH) for HER2 genomic ... Symposium. Using molecular test results from tumors with previously documented positive, negative, ...
(Date:12/2/2016)... ... December 01, 2016 , ... PhUSE will build ... popularity of US Single Day Events (SDE) to organize a multiple-day US conference. ... Raleigh, NC. Topics of the pharmaceutical and life sciences industry will cover industry ...
(Date:12/2/2016)... ... December 01, 2016 , ... DrugDev believes the only ... a beautiful technology experience. All three tenets were on display at the 2nd Annual ... from over 40 sponsor, CRO and site organizations to discuss innovation and the future ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... consortium of pharmaceutical and biotechnology companies dedicated to collaboratively developing improved chemistry, ... in supplying a vendor-supported, portable online UHPLC, with robust, probe-based sampling. ...
Breaking Biology Technology:
(Date:11/22/2016)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the company has been ... Awards as "Most Outstanding in eClinical Solutions" for ... recognition and growth for MedNet, which has effectively supported ... iMedNet ™ , MedNet,s flagship eClinical technology ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ownership types; ... Academics) market is to witness a value of US$37.1 billion ... Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from ... 2014-2020. North America is not way ... Europe at 9.56% respectively. Report Focus: ...
(Date:11/15/2016)... 2016  Synthetic Biologics, Inc. (NYSE MKT: SYN), ... the gut microbiome, today announced the pricing of ... its common stock and warrants to purchase 50,000,000 ... to the public of $1.00 per share and ... the offering, excluding the proceeds, if any from ...
Breaking Biology News(10 mins):